Literature DB >> 14321918

EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIV. FURTHER STUDY OF CERTAIN BASIC CONCEPTS UNDERLYING CHEMOTHERAPY OF LEUKEMIA.

H E SKIPPER, F M SCHABEL, W S WILCOX.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; EXPERIMENTAL LAB STUDY; LEUKEMIA, EXPERIMENTAL; MICE; PHARMACOLOGY

Mesh：

Substances：

Year:  1965        PMID： 14321918

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  14 in total

Review 1.  Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  Natural and asparaginase induced death of L5178Y leukemia cells in vivo.

Authors:  K G Hofer; J DiBenedetto; W L Hughes
Journal:  Z Krebsforsch       Date:  1970-11-20

3.  A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs.

Authors:  J B Le Pecq; C Gosse; C Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

4.  Evolution of a practical policy for chemotherapy of carcinoma of the breast.

Authors:  M L Sutton
Journal:  Proc R Soc Med       Date:  1973-12

Review 5.  Selective uptake and retention of anticancer agents by sensitive cells.

Authors:  D L Hill; J A Montgomery
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

6.  Reproducibility of survival time in L 5222 rat leukaemia and its implications for chemotherapeutic tests.

Authors:  D Hoelzer; E B Harriss
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1975

7.  High-dose cyclophosphamide followed by cisplatinum in the treatment of ovarian cancer.

Authors:  R Osborne; B Evans; C Gallagher; C Wood; M Slevin; J Shepherd; E Wiltshaw
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

8.  Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisation.

Authors:  J L Misset; G Mathé; M Tubiana; B Caillou; F de Vassal; P Pouillart; M Gil; C Tentas; M Hayat; L Schwarzenberg; C Jasmin; M Delgado; D Machover; P Ribaud; M Musset
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

9.  Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy.

Authors:  Sarah Crawford
Journal:  Front Pharmacol       Date:  2013-06-25       Impact factor: 5.810

10.  The effect of cyclophosphamide on the growth and cellular kinetics of a transplantable rat fibrosarcoma.

Authors:  S Peel; D M Cowen
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.